Consolidated income statement (IFRS)
from 1 October 2024 to 30 September 2025
|
|
Note |
|
2024/25 |
|
2023/24 |
|---|---|---|---|---|---|---|
|
|
|
|
€k |
|
€k |
Revenue |
|
|
2,227,645 |
|
2,066,127 |
|
Cost of sales |
|
|
|
-1,052,448 |
|
-977,497 |
Gross profit |
|
|
|
1,175,197 |
|
1,088,630 |
Selling and marketing expenses |
|
|
|
-495,098 |
|
-458,198 |
General administrative expenses |
|
|
|
-131,421 |
|
-111,010 |
Research and development expenses |
|
|
-326,275 |
|
-343,089 |
|
Other operating result |
|
|
917 |
|
18,119 |
|
Earnings before interest and taxes (EBIT) |
|
|
|
223,320 |
|
194,452 |
Result of investments carried at equity |
|
|
30 |
|
-3,022 |
|
Interest income |
|
|
6,570 |
|
22,396 |
|
Interest expenses |
|
|
-26,600 |
|
-29,424 |
|
Net interest from defined benefit pension plans |
|
|
-24 |
|
877 |
|
Foreign currency gains (+) / losses (-), net |
|
|
-10,463 |
|
11,584 |
|
Other financial result |
|
|
1,059 |
|
44,003 |
|
Earnings before income taxes (EBT) |
|
|
|
193,892 |
|
240,866 |
Income taxes |
|
|
-51,547 |
|
-60,712 |
|
Consolidated profit |
|
|
|
142,345 |
|
180,154 |
» of which profit/loss attributable to shareholders of the parent company |
|
|
|
141,210 |
|
178,726 |
» of which profit/loss attributable to non-controlling interests |
|
|
|
1,135 |
|
1,428 |
Earnings per share, basic/diluted (in €) (EPS) |
|
|
1.61 |
|
2.01 |